Company Pila Pharma AB

Equities

PILA

SE0015988274

Pharmaceuticals

Market Closed - Nasdaq Stockholm 08:49:42 31/05/2024 pm IST 5-day change 1st Jan Change
3.1 SEK +2.99% Intraday chart for Pila Pharma AB +10.71% +93.75%

Business Summary

Pila Pharma AB is a Sweden-based clinical stage pharmaceutical company, active in the biotechnology sector. The Company conducts clinical tests in phase 2 with drugs against type 2 diabetes. The target product is a tablet that is taken orally in an early stage of diabetes to restore the body's insulin production and thereby reduce the patient's blood sugar level. PILA PHARMA's patent-protected product candidate is called XEN-D0501 and is a TRPV1 antagonist, a novel type of oral anti-diabetic agent for treatment of type 2 diabetes. Pila Pharma AB has completed two phase 2a clinical trials (PP-CT01 and PP-CT02), that both demonstrated that XEN-D0501 is well tolerated by people with type 2 diabetes. In addition, the product is expected to have fewer unwanted side effects than alternative forms of treatment.

Number of employees: 1

Sales per Business

SEK in Million2022Weight2023Weight Delta
TRPV1 Antagonist
100.0 %
2 100.0 % 1 100.0 % -22.21%

Sales per region

SEK in Million2022Weight2023Weight Delta
Sweden
100.0 %
2 100.0 % 1 100.0 % -22.21%

Managers

Managers TitleAgeSince
Founder 55 01/14/01
Director of Finance/CFO 63 01/21/01

Members of the board

Members of the board TitleAgeSince
Chairman 70 01/16/01
Director/Board Member 58 30/23/30
Founder 55 01/14/01
Director/Board Member 57 30/23/30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 23,793,289 12,950,660 ( 54.43 %) 0 54.43 %

Company contact information

Pila Pharma AB

Norra Vallgatan 72

211 22, Malmö

+46 7 39 03 69 69

http://www.pilapharma.com
address Pila Pharma AB(PILA)
  1. Stock Market
  2. Equities
  3. PILA Stock
  4. Company Pila Pharma AB